Similar to Kuzelova et al., the authors demonstrated a low expression of HLA classes I and II in NPM1-mutated AML (with more primitive stem cell-like phenotypes) in which DNMT3A mutations are largely absent. This evidence concerns the gene DNMT3A and acute myeloid leukemia.